Shmuel Odes

Ben-Gurion University of the Negev — Israel

Biochemistry, Genetics and Molecular Biology · Life Sciences

19h-index1.7kcitations82works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(61), Microscopic Colitis(36), Health, psychology, and well-being(14), Eosinophilic Esophagitis(10), Adolescent and Pediatric Healthcare(8)

Publications82 total

HSD83 Patterns Of Adoption And Diffusion Of Biological Therapies In Inflammatory Bowel Disease: Patient-Centric Insights From Israel
Value in Health·2025
RWD281 LEVERAGING NATIONWIDE HEALTH AND INSURANCE RECORDS TO TRACK BIOLOGIC DRUG DIFFUSION IN IBD: A 20-YEAR REAL-WORLD STUDY FROM ISRAEL
Value in Health Regional Issues·2025Open Access
Gender Differences in Coping Strategies and Life Satisfaction Following Cognitive-Behavioral and Mindfulness-Based Intervention for Crohn’s Disease: A Randomized Controlled Trial
Journal of Clinical Medicine·2025· 6 citedOpen Access
Cognitive behavioral and mindfulness with daily exercise intervention is associated with changes in intestinal microbial taxa and systemic inflammation in patients with Crohn’s disease
Gut Microbes·2024· 13 citedOpen Access
Inflammatory bowel disease among first generation immigrants in Israel: A nationwide epi-Israeli Inflammatory Bowel Disease Research Nucleus study
World Journal of Methodology·2023Open Access
Effectiveness of Cognitive-Behavioral and Mindfulness Intervention in Improving Life Satisfaction of Patients with Crohn’s Disease: Evaluating Stress, Interpersonal Sensitivity, and Social Support as Mechanisms of Change
Mindfulness·2023· 6 cited
Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRN
Inflammatory Bowel Diseases·2023· 8 cited
Randomised clinical trial: Psychological intervention improves work productivity and daily activity by reducing abdominal pain and fatigue in Crohn's disease
Alimentary Pharmacology & Therapeutics·2023· 11 citedOpen Access
P860 The Costs of Inflammatory Bowel Diseases in High-Income Settings
Journal of Crohn s and Colitis·2023Open Access
Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease
Brain Behavior & Immunity - Health·2021· 28 citedOpen Access
UEG Week 2021 Moderated Posters
United European Gastroenterology Journal·2021· 1 citedOpen Access
P026 Microbial Diversity is affected by Cognitive Behavioral and Mindfulness-Based Stress Reduction and accompanied by an Inflammatory Response in Patients with Crohn’s Disease
Journal of Crohn s and Colitis·2021Open Access
P055 Brain-Immune Axis Regulation is Responsive to Cognitive Behavioral and Mindfulness-Based Stress Reduction in Crohn’s Disease
Journal of Crohn s and Colitis·2021Open Access
Randomized Controlled Trial of Cognitive-Behavioral and Mindfulness-Based Stress Reduction on the Quality of Life of Patients With Crohn Disease
Inflammatory Bowel Diseases·2021· 51 cited
Epidemiology of Inflammatory Bowel Diseases in Israel: A Nationwide Epi-Israeli IBD Research Nucleus Study
Inflammatory Bowel Diseases·2021· 50 cited
Normative data for the Brief Symptom Inventory for patients with Crohn's disease
Psychology and Health·2021· 3 cited
Differential relationships of somatization, depression, and anxiety to severity of Crohn’s disease
Journal of Health Psychology·2020· 19 cited
P332 Mindfulness-based stress reduction and cognitive intervention improve the health-related quality-of-life and ability to work in Crohn’s disease patients: A randomised controlled trial
Journal of Crohn s and Colitis·2020· 1 citedOpen Access
Can Multiparity Predict a Difficult Colonoscopy? Prospective, Single-Centre Study in an Orthodox Jewish Hospital in Israel
2020
PGI49 CHANGES IN HEALTH RELATED QUALITY OF LIFE IN CROHN'S DISEASE PATIENTS FOLLOWING MINDFULNESS-BASED COGNITIVE INTERVENTION: PRELIMINARY RESULTS OF A RANDOMIZED CONTROLLED TRIAL
Value in Health·2019· 1 cited
page 1 of 5Next →

Frequent Co-authors

Doron Schwartz(26), Michael Friger(21), Vered Slonim‐Nevo(20), Orly Sarid(20), Dan Greenberg(18), Ruslan Sergienko(17), Hillel Vardi(12), Yehuda Chowers(9), Shomron Ben‐Horin(9), Iris Dotan(9), Ganit Goren(9), Rami Eliakim(8), Alon Monsonego(8), Daniel Keter(7), Alexandra Lavy(7), Alexander Fich(7), Dan Turner(7), Shirley Regev(7), Anna Nemirovsky(7), Elena Chernin(7)